Clinical Trials
9 trialsNCT03117335 2017-04-17
Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung Cancer
Jiangsu Wuzhong Pharmaceutical Group Co., Ltd.
Phase 3 Completed
NCT03008109 2017-01-04
Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC
Air Force General Hospital of the PLA
Phase 3 Unknown
NCT02579564 2016-10-21
Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients
Xinqiao Hospital of Chongqing
Phase 3 Unknown
NCT02907710 2016-09-20
Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma
First Affiliated Hospital of Guangxi Medical University
Phase 3 Unknown
NCT02630264 2015-12-15
E10A for the Treatment of Squamous Cell Carcinoma of the Head and Neck
Guangzhou Double Bioproducts Co., Ltd
Phase 3 Unknown
NCT01915134 2015-01-01
Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital
Phase 3 Unknown
NCT01479036 2011-11-24
CBCRT01
Xijing Hospital
Phase 3 Unknown
NCT01124253 2010-05-17
Dengshan
Shanghai Jiao Tong University School of Medicine
Phase 3 Completed
NCT00576914 2010-03-09
Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer
Chinese Academy of Sciences
Phase 3 Unknown